Stocks in Play: Crescita Therapeutics Inc.
Wednesday, May 14, 202510:09 AM EST - Crescita Therapeutics Inc. : Today reported its financial results for the first quarter ended March 31, 2025. Revenue was $3,537, compared to $4,996, a decrease of $1,459. Gross profit was $1,747, compared to $2,411, a decrease of $664. Operating expenses were $2,809, compared to $3,142, a decrease of $333. Net loss was $(932), compared to $(626), an increase of $306. Crescita Therapeutics Inc. (T.CTX) shares were down $0.01 at 0.52.Stocks in Play: Crescita Therapeutics Inc., Thu, 15 May 2025 03:42:05 EST
Recent Posts
Kosovo Votes in Election Aimed at Breaking Political Deadlock
‘The past gives comfort’: Finding refuge on analog islands amid deepening digital seas
Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board
Brazilian judge puts coup plot convicts under house arrest after former police commander flees
US Lukoil Gas Station Owners Left in Limbo Over Russia Sanctions
What’s in the mix, and what’s at risk, for 2026: FP Video
In orbit: Canada’s satellite-to-cell offerings poised to grow after Rogers beta trial
Inside the failed green revolutions at BP and Shell
Zelenskiy Prepares for Trump Meeting as Russia Bombards Kyiv
Sure, the newspaper informed. But as it fades, those who used it for other things must adjust, too
